PRME
Prime Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.83
+10.37%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 66.93x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 17.45x
- Price / sales
- 170.56x
- Price / cash flow
- -4.45x
Enterprise value
- Enterprise value
- $712.1M
- EV / sales
- 174.83x
- EV / EBITDA
- -3.95x
- EV / EBIT
- -3.62x
- Market cap
- $694.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026